AHA 2020: RHAPSODY Phase 3 Trial — Dr Allan Klein
- Видео
- О видео
- Скачать
- Поделиться
AHA 2020: RHAPSODY Phase 3 Trial — Dr Allan Klein
Dr Allan Klein (Cleveland Clinic, Cleveland, Ohio, US) discusses the positive results of the Phase 3 RHAPSODY trial. The trial is investigating the use of rilonacept, an IL-1α And IL-1β trap, in resolving and reducing the risk of recurrence in patients with recurrent pericarditis. Questions: 1. What is the background of this study? 2. What is the study design? 3. What were the results? 4. What conclusions can be made? 5. In light of the results, do you anticipate FDA approval, if so, when? 6. What are the 'take-home' messages for clinicians? Recorded remotely from Cleveland, 2020. Interviewer: Victoria Perroud Recording Editor: Tom Green
564 | 4 год. назад | 9 - 0
Dr Allan Klein (Cleveland Clinic, Cleveland, Ohio, US) discusses the positive results of the Phase 3 RHAPSODY trial. The trial is investigating the use of rilonacept, an IL-1α And IL-1β trap, in resolving and reducing the risk of recurrence in patients with recurrent pericarditis.
Questions:
1. What is the background of this study?
2. What is the study design?
3. What were the results?
4. What conclusions can be made?
5. In light of the results, do you anticipate FDA approval, if so, when?
6. What are the 'take-home' messages for clinicians?
Recorded remotely from Cleveland, 2020.
Interviewer: Victoria Perroud
Recording Editor: Tom Green
Чтобы скачать видео "AHA 2020: RHAPSODY Phase 3 Trial — Dr Allan Klein" передвинте ползунок вправо
- Комментарии
Комментарии ФБ